Clinical Aspergillus signatures in COPD and bronchiectasis
Pulmonary mycoses remain a global threat, causing significant morbidity and mortality. Patients with airways disease, including COPD and bronchiectasis, are at increased risks of pulmonary mycoses and its associated complications. Frequent use of antibiotics and corticosteroids coupled with impaired...
Saved in:
Main Authors: | Tiew, Pei Yee, Thng, Kai Xian, Chotirmall, Sanjay Haresh |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/162879 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Immunological corollary of the pulmonary mycobiome in bronchiectasis : the CAMEB study
by: Mac Aogáin, Micheál, et al.
Published: (2019) -
Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017) -
Microbiology and the microbiome in bronchiectasis
by: Mac Aogáin, Micheál, et al.
Published: (2023) -
Bronchiectasis: new therapies and new perspectives
by: Chalmers, James D, et al.
Published: (2018) -
RESPIRE : breathing new life into bronchiectasis
by: Chalmers, James D., et al.
Published: (2019)